David Campbell

David Campbell is an experienced finance professional with a strong background in executive management and forecasting. Currently serving as a CFO Consultant at both Camallergy and MicrosensDx, David has developed extensive skills in financial strategy. Previously, as Finance Director at Healx and at Sartorius Stedim Biotech, David honed expertise in private equity and management across various regions. David’s early career included a significant role as Finance Director at TAP Biosystems, where a focus on forecasting and executive management was emphasized. David holds an MBA in Financial Planning and Financial Analysis from Alliance Manchester Business School.